Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) saw a large decline in short interest during the month of December. As of December 15th, there was short interest totaling 86,655 shares, a decline of 31.2% from the November 30th total of 125,952 shares. Approximately 11.9% of the shares of the stock are sold short. Based on an average daily volume of 940,286 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 940,286 shares, the short-interest ratio is presently 0.1 days. Approximately 11.9% of the shares of the stock are sold short.
Aditxt Stock Down 8.0%
NASDAQ:ADTX opened at $1.03 on Tuesday. The stock has a fifty day simple moving average of $6.42 and a 200 day simple moving average of $78.64. The firm has a market capitalization of $751,900.00, a price-to-earnings ratio of 0.00 and a beta of 1.43. Aditxt has a 1-year low of $1.00 and a 1-year high of $6,412.75.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.
About Aditxt
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Further Reading
- Five stocks we like better than Aditxt
- Your “birthright claim” just got activated
- Wall Street Stockpicker Names #1 Stock of 2026
- The McDonald’s Secret
- Terrifying reason Trump killed the U.S. penny?
- Turn your “dead money” into $306+ monthly (starting this month)
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
